The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

NCT05547529 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
156
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Blokhin's Russian Cancer Research Center